ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 75 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $297,000 | -71.9% | 114,240 | -58.0% | 0.00% | -75.0% |
| Q3 2016 | $1,057,000 | +44.6% | 271,770 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $731,000 | -12.7% | 271,770 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $837,000 | -20.0% | 271,770 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $1,046,000 | +26.2% | 271,770 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $829,000 | -39.0% | 271,770 | -15.1% | 0.00% | -40.0% |
| Q2 2015 | $1,358,000 | +9.9% | 320,170 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $1,236,000 | -40.0% | 320,170 | +4.6% | 0.00% | -42.9% |
| Q4 2014 | $2,060,000 | +22.6% | 306,070 | 0.0% | 0.01% | +16.7% |
| Q3 2014 | $1,680,000 | -4.3% | 306,070 | +78.7% | 0.01% | 0.0% |
| Q2 2014 | $1,756,000 | -14.6% | 171,270 | 0.0% | 0.01% | -25.0% |
| Q1 2014 | $2,057,000 | +12.5% | 171,270 | +5.9% | 0.01% | +14.3% |
| Q4 2013 | $1,828,000 | +64.4% | 161,670 | +56.6% | 0.01% | +40.0% |
| Q3 2013 | $1,112,000 | – | 103,270 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |